Advertisement
Advertisement

BBLG

B

Bone Biologics Corp

1.02
USD
-0.03
-2.86%
Dec 20, 15:56 UTC -5
Closed
...

BBLG Cash Flow


Expand Categories

ItemTTM
12/31/202312/31/202212/31/2021
Cash Flow From Operating Activities
-4.789-9.556-3.567-1.229
Consolidated Net Income (Loss)
-0.571-8.949-1.485-1.611
Total Non-Cash Items
0.097-0.74-1.9140.703
Stock-Based Compensation
0.1590.1530.2670.207
Other Non-Cash Items
-0.063-0.893-2.1810.496
Total Changes in Assets/Liabilities
-0.7450.133-0.168-0.321
Change in Accounts Payable & Accrued Liability
0.120.2560.005-0.366
Change in Assets/Liabilities
-0.866-0.123-0.1730.045
Cash Flow From Financing Activities
3.9035.0444.437.904
Debt Issuance (Retirement), Net - Total
------1.045
Net Current Debt
------1.045
Short-Term Debt Issued
------1.045
Net Total Equity Issued (Repurchased)
3.9035.0444.436.859
Net Common Equity Issued (Repurchased)
3.9035.0444.436.859
Common Shares Issued
3.9035.0444.436.859
Increase (Decrease) in Cash
-0.886-4.5120.8636.675
Beginning Cash
3.0277.5386.675--
End Cash
2.143.0277.5386.675

In Millions of USD (except for per share items).

Advertisement